BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22240623)

  • 1. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.
    Krönke A; Schlaak M; Arin M; Mauch C; Kurschat P
    Eur J Dermatol; 2012; 22(2):259-60. PubMed ID: 22240623
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
    Coors EA; Von den Driesch P
    Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024
    [No Abstract]   [Full Text] [Related]  

  • 3. Follicular mycosis fungoides: successful treatment with oral bexarotene.
    Shistik G; Scalf LA; Fenske N; Glass LF
    J Drugs Dermatol; 2004; 3(3):301-4. PubMed ID: 15176165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
    Stern DK; Lebwohl M
    J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.
    Coors E
    Dermatol Clin; 2008 Jan; 26 Suppl 1():33-5. PubMed ID: 18405185
    [No Abstract]   [Full Text] [Related]  

  • 6. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M; García-Arpa M; González-García J
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
    Dalle S; Thomas L
    Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
    Wirtz M; Helbig D
    Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folliculotropic mycosis fungoides responding to bexarotene gel.
    Walling HW; Swick BL; Gerami P; Scupham RK
    J Drugs Dermatol; 2008 Feb; 7(2):169-71. PubMed ID: 18335654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folliculotropic mycosis fungoides and a leonine clinical appearance of the face.
    Ito T; Yamamoto T; Matsumoto Y; Wakamatsu J; Kato Y; Tsuboi R
    Dermatol Online J; 2008 Sep; 14(9):6. PubMed ID: 19061588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
    D'Acunto C; Gurioli C; Neri I
    J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained remission of treatment-resistant cutaneous T-cell lymphoma with oral bexarotene.
    Mehlmauer MA
    Cutis; 2004 Jun; 73(6):417-20. PubMed ID: 15224787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
    Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
    Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular mycosis fungoides: variability of a rare entity.
    Roeschm A; Schleyer V; Landthaler M; Vogt T
    Skinmed; 2005; 4(1):12-7. PubMed ID: 15654159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bexarotene monotherapy for patients with advanced stage mycosis fungoides.
    Bachelez H
    Dermatol Clin; 2008 Jan; 26 Suppl 1():25-6. PubMed ID: 18405183
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides.
    Michaelis S; Cozzio A; Kempf W; Graf P; Burg G; Dummer R
    Dermatology; 2004; 209(1):72-4. PubMed ID: 15237276
    [No Abstract]   [Full Text] [Related]  

  • 17. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
    Huang J; Cowper S; Moss J; Girardi M
    J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical bexarotene for psoralen plus ultraviolet A-induced photodamage.
    Deonizio JM; Vaghani SP; Guitart J
    J Am Acad Dermatol; 2013 Aug; 69(2):e96-8. PubMed ID: 23866897
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.
    Otremba B
    Dermatol Clin; 2008 Jan; 26 Suppl 1():51-2. PubMed ID: 18405188
    [No Abstract]   [Full Text] [Related]  

  • 20. Foreign-body-associated granulomatous slack skin in folliculotropic mycosis fungoides of childhood.
    Tronnier M
    J Cutan Pathol; 2009 May; 36(5):578-81. PubMed ID: 19476528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.